Sparing Vision

Beacon Therapeutics

This company develops ophthalmic gene therapies to restore vision for patients with rare and prevalent retinal diseases causing blindness.

Ray Therapeutics

The company develops optogenetic gene therapies to restore vision for patients with blinding retinal diseases.

Atsena

This clinical-stage gene therapy company develops genetic medicines to reverse or prevent blindness for patients with inherited retinal diseases.

Nightstar

This company develops gene therapies for patients with rare inherited retinal diseases that cause progressive blindness.

RhyGaze

This biotechnology company develops optogenetic gene therapies to restore vision for patients with retinal diseases causing blindness.

GenSight Biologics

This company develops gene therapies for patients suffering from neurodegenerative retinal diseases and central nervous system disorders.

Restore Vision

This clinical-stage biotechnology company develops visual restoration gene therapies to treat blindness caused by genetic retinal disorders for patients with retinitis pigmentosa.

Vedere

The company develops optogenetics-based gene therapies to restore vision for patients with inherited retinal dystrophies and geographic atrophy.